Myelotib 200 mg Capsule 28's Substitute
by AYUR
by Others
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
NILOTINIB-200MG
Uses:
Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)
Medicinal Benefits:
Myelotib 200 mg Capsule 28's contains Nilotinib, an anticancer drug used to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). In chronic myeloid leukemia (CML) patients, a change in genetic material (DNA) triggers a signal that tells the body to produce more abnormal white blood cells (cancerous cells). Nilotinib works by blocking this signal and thus stops the production of cancerous cells. Myelotib 200 mg Capsule 28's is used in adults and children with newly diagnosed Ph+ CML in the chronic phase and in adults with Ph+ CML in the accelerated and chronic phase who did not tolerate or no longer benefit from other treatments, including Imatinib.
Myelotib 200 mg Capsule 28's contains Nilotinib, an anticancer drug. In chronic myeloid leukemia (CML) patients, a change in genetic material (DNA) triggers a signal that tells the body to produce more abnormal white blood cells (cancerous cells). Nilotinib works by blocking this signal and thus stops the production of cancerous cells.
You are not recommended to take antacids and Myelotib 200 mg Capsule 28's at the same time. You are advised to take antacids containing magnesium hydroxide, aluminium hydroxide, and simethicone about two hours before or two hours after taking Myelotib 200 mg Capsule 28's. However, please consult a doctor before taking other medicines with Myelotib 200 mg Capsule 28's.
You are recommended to avoid grapefruit juice, grapefruit and any supplement containing grapefruit extract while taking Myelotib 200 mg Capsule 28's as it may increase the amount of Nilotinib in the body and cause serious side effects.